Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Dysregulated relationship of inflammation and oxidative stress in major depression.

Rawdin BJ, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y, Burke HM, Reus VI, Rosser R, Hamilton SP, Nelson JC, Wolkowitz OM.

Brain Behav Immun. 2013 Jul;31:143-52. doi: 10.1016/j.bbi.2012.11.011. Epub 2012 Nov 29.

2.

Oxidative stress, inflammation and treatment response in major depression.

Lindqvist D, Dhabhar FS, James SJ, Hough CM, Jain FA, Bersani FS, Reus VI, Verhoeven JE, Epel ES, Mahan L, Rosser R, Wolkowitz OM, Mellon SH.

Psychoneuroendocrinology. 2017 Feb;76:197-205. doi: 10.1016/j.psyneuen.2016.11.031. Epub 2016 Nov 30.

PMID:
27960139
3.

Increased oxidative stress in patients with depression and its relationship to treatment.

Chung CP, Schmidt D, Stein CM, Morrow JD, Salomon RM.

Psychiatry Res. 2013 Apr 30;206(2-3):213-6. doi: 10.1016/j.psychres.2012.10.018. Epub 2012 Dec 11.

4.

Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.

Bot M, Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Mann DL.

J Psychosom Res. 2011 Jul;71(1):13-7. doi: 10.1016/j.jpsychores.2010.11.006. Epub 2011 Jan 15.

5.

Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings.

Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar FS, Su Y, Reus VI, Rosser R, Burke HM, Kupferman E, Compagnone M, Nelson JC, Blackburn EH.

PLoS One. 2011 Mar 23;6(3):e17837. doi: 10.1371/journal.pone.0017837.

6.

Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder.

Chang CC, Lee CT, Lan TH, Ju PC, Hsieh YH, Lai TJ.

Psychiatry Res. 2015 Dec 15;230(2):575-80. doi: 10.1016/j.psychres.2015.10.006. Epub 2015 Oct 9.

PMID:
26476591
7.

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.

Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S.

J Affect Disord. 2012 Dec 10;141(2-3):308-14. doi: 10.1016/j.jad.2012.03.033. Epub 2012 Apr 18.

PMID:
22516310
8.

Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study.

Xiong GL, Prybol K, Boyle SH, Hall R, Streilein RD, Steffens DC, Krishnan R, Rogers JG, O'Connor CM, Jiang W; SADHART-CHF Investigators..

Psychosom Med. 2015 Sep;77(7):808-15. doi: 10.1097/PSY.0000000000000216.

9.

Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder.

Behr GA, Moreira JC, Frey BN.

Oxid Med Cell Longev. 2012;2012:609421. doi: 10.1155/2012/609421. Epub 2012 May 27. Review.

10.

Is depression associated with increased oxidative stress? A systematic review and meta-analysis.

Black CN, Bot M, Scheffer PG, Cuijpers P, Penninx BW.

Psychoneuroendocrinology. 2015 Jan;51:164-75. doi: 10.1016/j.psyneuen.2014.09.025. Epub 2014 Oct 2. Review.

11.

Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression.

Joaquim HP, Talib LL, Forlenza OV, Diniz BS, Gattaz WF.

J Psychiatr Res. 2012 Aug;46(8):1053-8. doi: 10.1016/j.jpsychires.2012.04.020. Epub 2012 May 22.

PMID:
22622071
12.

Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study.

Michalakeas CA, Parissis JT, Douzenis A, Nikolaou M, Varounis C, Andreadou I, Antonellos N, Markantonis-Kiroudis S, Paraskevaidis I, Ikonomidis I, Lykouras E, Kremastinos D.

J Card Fail. 2011 Sep;17(9):748-54. doi: 10.1016/j.cardfail.2011.05.004. Erratum in: J Card Fail. 2011 Oct;17(10):877. Lykouras, Evaggelos [corrected to Lykouras, Elefterios].

PMID:
21872145
13.

Connection between inflammatory markers, antidepressants and depression.

Crnković D, Buljan D, Karlović D, Krmek M.

Acta Clin Croat. 2012 Mar;51(1):25-33.

PMID:
22919999
14.

Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression.

Gill J, Luckenbaugh D, Charney D, Vythilingam M.

Biol Psychiatry. 2010 Dec 1;68(11):999-1006. doi: 10.1016/j.biopsych.2010.07.033. Epub 2010 Oct 15.

PMID:
20951370
15.

Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study.

Hoffman BM, Babyak MA, Craighead WE, Sherwood A, Doraiswamy PM, Coons MJ, Blumenthal JA.

Psychosom Med. 2011 Feb-Mar;73(2):127-33. doi: 10.1097/PSY.0b013e31820433a5. Epub 2010 Dec 10.

16.

Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.

Dunjic-Kostic B, Ivkovic M, Radonjic NV, Petronijevic ND, Pantovic M, Damjanovic A, Poznanovic ST, Jovanovic A, Nikolic T, Jasovic-Gasic M.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:1-6. doi: 10.1016/j.pnpbp.2012.11.009. Epub 2012 Nov 28.

PMID:
23200828
18.

Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study.

Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1;35(5):1284-90. doi: 10.1016/j.pnpbp.2011.03.021. Epub 2011 Apr 15.

PMID:
21515329
19.

Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.

Amsterdam JD, Williams D, Michelson D, Adler LA, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF.

Neuropsychobiology. 2009;59(4):227-33. doi: 10.1159/000226611. Epub 2009 Jul 2.

PMID:
19571597
20.

Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.

Victor TA, Furey ML, Fromm SJ, Öhman A, Drevets WC.

Int J Neuropsychopharmacol. 2013 Nov;16(10):2195-208. doi: 10.1017/S146114571300062X. Epub 2013 Jul 1.

PMID:
23809145

Supplemental Content

Support Center